Prof. Dr. Dr. h.c. Stefan H. E. Kaufmann

Prof. Dr. Dr. h.c. Stefan H. E. Kaufmann

Scientific member (Director)

Organizational Unit (Department, Group, Facility):

  • Immunology
  • Max Planck Institute for Infection Biology

Founding Director of the Max Planck Institute for Infection Biology in Berlin, Germany, where he heads the Department of Immunology. Professor of Microbiology and Immunology, Charité University Clinics Berlin, Germany. Faculty Fellow of the Hagler Institute for Advanced Study at Texas A & M University, College Station, Texas. Studied biology at the Johannes Gutenberg University of Mainz, Germany, 1977 PhD (highest degree, summa cum laude). From 1987 to 1991 Professor for Medical Microbiology and Immunology, and from 1991 to 1998 full Professor for Immunology at the University of Ulm. Doctor Honoris Causa from the Aix-Marseille University. Fellow of the Royal College of Physicians of Edinburgh (FRCP Edin). Honorary Professor of the Universidad Peruana Cayetano Heredia, Lima, Peru; Guest Professor at Tongji University, School of Medicine, Shanghai, China; Visiting Professor, Peking Union Medical College, Beijing, China. Scientific interests: immunity to bacterial pathogens with emphasis on tuberculosis and rational design of vaccines and biosignatures. Developer of a tuberculosis vaccine which has reached phase III clinical trial. Former President and honorary member of the German Society for Immunology. Former President of the European Federation of Immunological Societies and of the International Union of Immunological Societies. Member of the Executive Committee of the Robert Koch Foundation. Chair of the Board of the Schering Foundation. Member of the Scientific Advisory Board and member of the Board of Trustees of the Lindau Nobel Laureate Meetings. Board Member of the Global Alliance for Vaccines and Immunisation (GAVI) from 2010 to 2013. From 2009 to 2014 member of the Scientific Board of the Global Alliance for TB Drug Development (TB Alliance). Member of the Strategic Advisory Committee of the European and Developing Countries Clinical Trials Partnership (EDCTP) from 2014 to 2018. Initiator of the global Day of Immunology to raise public awareness in immunology. Scientific advisor on “Health” for the G7 summit in Elmau, Germany, in 2015 as well as for the G20 summit in Hamburg in 2017. Numerous prestigious scientific awards, most recently Gagna A. & Ch. Van Heck Prize. Coordinator of several international and interdisciplinary projects, e.g. Grand Challenge 6 of the Bill and Melinda Gates Foundation from 2005 to 2016. More than 900 publications mostly in high-ranking journals with more than 60,000 citations and an h-index of 130 according to Google Scholar; Thomson/ISI: 105. Editor or member of editorial boards of many international scientific journals and of numerous professional societies and academies including American Academy of Microbiology, Berlin–Brandenburg Academy of Sciences and Humanities, German National Academy of Sciences Leopoldina, World Innovation Foundation and European Molecular Biology Organization (EMBO).


Go to Editor View